Short-Course chemotherapy for tuberculosis with mainly twice-weekly isoniazid and rifampin
- 1 August 1984
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 77 (2) , 233-242
- https://doi.org/10.1016/0002-9343(84)90697-1
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Undesirable Side Effects of Isoniazid and Rifampin in Largely Twice-Weekly Short-Course Chemotherapy for TuberculosisAmerican Review of Respiratory Disease, 1983
- Nine-Month Chemotherapy for Pulmonary TuberculosisSouthern Medical Journal, 1982
- Whither short-course chemotherapy?Respiratory Medicine, 1981
- Side-effects of drug regimens used in short-course chemotherapy for pulmonary tuberculosis. A controlled clinical studyTubercle, 1980
- The Chemotherapy of Pulmonary Tuberculosis: A ReviewChest, 1979
- Patient Compliance: The Most Serious Remaining Problem in the Control of Tuberculosis in the United StatesChest, 1979
- Short-course Chemotherapy for Tuberculosis with Largely Twice-weekly Isoniazid-RifampinChest, 1979
- Adverse reactions to rifampicin in antituberculosis regimensJournal of Antimicrobial Chemotherapy, 1977
- The therapy of pulmonary tuberculosis in Kenya: A comparison of the results achieved in controlled clinical trials with those achieved by the routine treatment servicesTubercle, 1970
- Domiciliary drug therapy of pulmonary tuberculosis in a rural population in IndiaTubercle, 1968